10

ANNUAL REPORT 2013-2014

ADVANCING THE BPS STRATEGIC PLAN

The well-structured, mixed FIP annual congress

Programme Committee has been and is preparing

balanced annual conferences where, as far as

possible, sessions profit from science and practice.

One of the highlights of this integrated approach

was the successful Dublin conference on meeting

the challenges of complex patients.

This congress was a natural follow-up to the FIP

centennial congress in Amsterdam, where the

responsible use of medicines was promoted: the

intelligent use of available treatments needs input

from practitioners and scientists. To get things

working, training and education are of high

importance.

On the level of the special interest and focus groups,

the BPS sponsored or co-sponsored local and regional

activities in several countries. At BPS level, support

to the Scientific Planning Committee for the 2014

Pharmaceutical Sciences World Congress in

Melbourne, Australia, helped get a high-level

conference programme together.

The next steps are the further development of

collaborations between BPS, Board of Pharmaceutical

Practice and FIP Education Initiative activities, all

with the aim of stimulating the responsible use of

medicines.

Henk de Jong

Scientific secretary

With the new structure of special interest and focus groups, the Board of Pharma ceutical Sciences (BPS) has worked to ensure that most of the pharmaceutical sciences fields are covered. Collaboration between practitioners, educators and scientists is, for FIP, a main strategic objective.

NOTES FROM THE BOARD OF PHARMACEUTICAL SCIENCES